Akorn acquires NDA and all privileges to Betimol from Santen Akorn, Inc http://www.sildenafil-online.org/category/humans-deceases .25 percent & 0.5 percent from Santen. This acquisition further enhances our system and growth possibilities in 2014.’ Financial Impact of the Transaction This transaction is expected to add around $8 million to $9 million in revenues to 2014 and approximately $0.03 to $0.04 of adjusted net income per diluted share.
The Notes will become convertible into shares of Akorn’s common stock, money, or a combination thereof. The interest, conversion rate, conversion cost and other conditions of the Notes will be determined at the proper time of prices of the offering. Akorn intends to use the net proceeds from the sale of the Notes for general corporate reasons, including potential potential acquisitions and strategic transactions. Akorn does not have any pending understanding or contract with respect to such acquisition or transaction.. Akorn intends to offer $100M of Convertible Senior Notes thanks 2016 Akorn, Inc. announced today that, at the mercy of market circumstances, it intends to offer $100 million principal amount of Convertible Senior Notes credited 2016 . The Notes are on offer and then qualified institutional buyers pursuant to Rule 144A beneath the Securities Work of 1933, as amended .